|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||277.749 g/mol g·mol−1|
|3D model (JSmol)|
|(what is this?)|
JNJ-7777120 is a drug being developed by Johnson & Johnson Pharmaceutical Research & Development which acts as a potent and selective antagonist at the histamine H4 receptor. It has anti-inflammatory effects, and has been demonstrated to be superior to traditional antihistamines in the treatment of pruritus (itching).
|This pharmacology-related article is a stub. You can help Wikipedia by expanding it.|